• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CODMAN & SHURTLEFF, INC. / MEDOS S.A. CERTAS INLIN VLV SPHN/UNIT CAT; SHUNT, CENTRAL NERVOUS SYSTEM & COMPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CODMAN & SHURTLEFF, INC. / MEDOS S.A. CERTAS INLIN VLV SPHN/UNIT CAT; SHUNT, CENTRAL NERVOUS SYSTEM & COMPS Back to Search Results
Catalog Number 82-8806
Device Problems Material Rupture (1546); Obstruction of Flow (2423)
Patient Problem No Information (3190)
Event Date 09/13/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).Upon completion of the investigation a follow up report will be filed.
 
Event Description
The valve was implanted to the patient via lp-shunt.Doi was unknown and with initial setting 4.After a few day, ventricular enlargement was observed.The pressure setting was reduced but the issue continued.Obstruction was suspected and reoperation was performed on (b)(6) during the procedure, it was found that the valve and the sg were ruptured.Therefore, the valve was explanted and implanted a new one.The product will be returned to your site.
 
Manufacturer Narrative
The valve was returned for evaluation.The position of the cam when valve was received was at setting 1.The valve was visually inspected: the housing was torn at the level of the siphonguard.The valve was tested for programming according and passed.The valve was flushed, no occlusion was noted.The valve was not reflux and leak tested as the housing was torn.The siphon guard was removed.No issues were found with the siphonguard.The valve was then pressure tested and passed the test.Review of the history device records was not possible as the lot number is unknown.The root cause of the occlusion suspected by the customer was not identified as no occlusion was found during the investigation.The root cause for the tear/cut in the silicone housing is probably due to the user.As noted in the ifu silicone has a low tear / cut resistance.Through a previous investigation, it was concluded that silicone housing tears are not design related, in order for the housing tear to occur the user has to compromise the silicone through a nick or tear in order for the event to occur.Validation testing demonstrates a robust design.Testing has shown that if the silicone housing has been compromised, a housing tear is likely to occur.Trends will be monitored for this or similar complaints.At present, we consider this complaint to be closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CERTAS INLIN VLV SPHN/UNIT CAT
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM & COMPS
Manufacturer (Section D)
CODMAN & SHURTLEFF, INC. / MEDOS S.A.
rue girardet 29
le locle CH 24 00
SZ  CH 2400
Manufacturer Contact
james kenney
325 paramount drive
raynham, MA 02767
5088282726
MDR Report Key6936088
MDR Text Key89170177
Report Number1226348-2017-10746
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K112156
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Medical Equipment Company Technician/Representative
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/10/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number82-8806
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/04/2017
Is the Reporter a Health Professional? No
Date Manufacturer Received12/05/2017
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-